Oct 5 (Reuters) – U.S. stocks jumped on Monday, with the S&P
500 rising for the fifth day in a row, as rising oil prices
boosted energy stocks and investors bet the Federal Reserve
would not raise interest rates this year.
The S&P’s five-day rise of 5.6 percent was its best five
days back to late 2011. Monday saw strong increases in
industrials, energy, telecommunications and materials stocks.
By Sinead Carew
(Reuters) – U.S. stocks rose on Monday, with the S&P 500 up for the fifth day, as investors bet the Federal Reserve will not raise interest rates this year.
Friday’s U.S. nonfarm payrolls report for September showed job growth slowed in the last three months, increasing prospects that the era of near-zero interest rates will continue for a while yet.
Oct 1 (Reuters) – The S&P 500 and the Nasdaq closed slightly
higher on Thursday in a choppy start to the fourth quarter as
investors waited for the monthly U.S. jobs report and the
quarterly earnings season.
After starting with a brief rally, stocks fell before edging
up again after the latest in a spate of volatile trading days
for an equities market where rallies quickly evaporate amid
uncertainty about the global economy and U.S. interest rates.
By Sinead Carew
(Reuters) – Wall Street started the last quarter of the year in the red in a choppy trading session as investors fled utilities and telecoms while they parsed mixed U.S. data.
After starting the day with a brief rally, stocks fell throughout the morning, then pared losses on Thursday afternoon. But the three major U.S. indexes were still in negative territory later in the session.
Sept 30 (Reuters) – U.S. stocks closed sharply higher on
Wednesday as investors sought bargains among beaten-down stocks
and the recently battered biotechnology index bounced back on
the last day of Wall Street’s worst quarter since 2011.
For much of the third quarter, global markets were rocked by
fears of slowing growth in China and uncertainty over timing for
a U.S. Federal Reserve hike of interest rates. Biotech had a
seven-day selloff kicked off by drug price regulation worries.
Sept 30 (Reuters) – U.S. stocks rose on Wednesday as
investors picked up beaten-down stocks, but all three major
indexes were on track for their worst quarter since 2011.
For most of the third quarter, global markets were rocked by
fears of slowing growth in China. Adding to the uncertainty, the
U.S. Federal Reserve held off on raising interest rates at its
By Sinead Carew
(Reuters) – A seven-day selloff of U.S. biotechnology stocks has hit sector investors – especially hedge funds – hard. But some managers say it was overdone and are already eyeing bargains such as Gilead Sciences Inc (GILD.O: Quote, Profile, Research, Stock Buzz) and Amgen Inc (AMGN.O: Quote, Profile, Research, Stock Buzz).
The Nasdaq Biotechnology index has fallen 18.7 percent over the last seven sessions as investors took flight after Hillary Clinton, front-runner to be the Democratic nominee in next year’s U.S. presidential election, vowed on Sept. 21 to take steps to curb high drug prices. Since its July 20 high, the index has fallen around 27 percent.
CHICAGO/NEW YORK, Sept 28 (Reuters) – Investors in U.S.
railroad stocks, who have been punished in 2015 by an
accelerating decline in high-margin coal shipments, now are
pinning their long-term hopes on a resurgence in consumer
Their bet is that a strengthening economy will produce
enough demand that railroads will be able to replace the income
lost to years of declining coal use with so-called intermodal
shipping – the movement of containers stuffed with clothing,
furniture and other consumer goods.
Sept 24 (Reuters) – U.S. stocks closed lower on Thursday in
a volatile session on uncertainty about U.S. monetary policy and
global economic growth, while market heavyweight Caterpillar cut
in its sales forecast and healthcare investors fled for the
Six of the 10 major S&P sectors were lower, with the health
sector’s 1-percent fall leading the S&P declines and
the Nasdaq biotech sector down 2 percent. Both healthcare
indexes had their fifth straight day of losses.
Sept 24 (Reuters) – Key U.S. stock indexes fell in afternoon
trading on Thursday, weighed by tumbling healthcare stocks and
shares of market heavyweight Caterpillar after a cut in its
sales forecast added to worries over sluggish global growth.
Eight of the 10 major S&P sectors were lower, with the
health sector’s 1.4 percent fall leading the declines.
The Nasdaq biotech sector was down 2.8 percent. Both
indexes were on track for a fifth straight day of losses.